Factors affecting prognosis in patients treated with bevacizumab plus paclitaxel as first-line chemotherapy for HER2-negative metastatic breast cancer: an international pooled analysis of individual patient data from four prospective observational studies

Autor: Yamamoto, Yutaka, Yamashiro, Hiroyasu, Schneeweiss, Andreas, Müller, Volkmar, Gluz, Oleg, Klare, Peter, Aktas, Bahriye, Magdolna, Dank, Büdi, László, Pikó, Béla, Mangel, László, Toi, Masakazu, Morita, Satoshi, Ohno, Shinji

Publikováno v: Breast Cancer (13406868); Jan2023, Vol. 30 Issue 1, p88-100, 13p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Capecitabine in Combination with Docetaxel in First Line in HER2-Negative Metastatic Breast Cancer: an Observational Study.

Autor: Kószó R; Department of Oncotherapy, University of Szeged, Korányi fasor 12, Szeged, 6720, Hungary., Sántha D; Department of Oncotherapy, University of Szeged, Korányi fasor 12, Szeged, 6720, Hungary., Büdi L; Borsod-Abauj-Zemplén County Hospital, Szentpéteri kapu 72-76, Miskolc, 3526, Hungary., Erfán J; Szabolcs-Szatmár-Bereg County Jósa András Hospital, Szent István u. 68, Nyíregyháza, 4400, Hungary., Győrfy K; Kaposi Mór Teaching Hospital, Tallián Gy. u. 20-32, Kaposvár, 7400, Hungary., Horváth Z; Medical Center, University of Debrecen, Nagyerdei krt. 98, Debrecen, 4032, Hungary., Kocsis J; 3rd Department of Internal Medicine, Semmelweis University, Kútvölgyi út 4, Budapest, 1125, Hungary., Landherr L; Uzsoki Hospital, Uzsoki u. 29-41, Budapest, 1145, Hungary., Hitre E; National Institute of Oncology, Ráth György u. 7-9, Budapest, 1126, Hungary., Máhr K; Zala County Hospital, Zrínyi M. u. 1, Zalaegerszeg, 8900, Hungary., Pajkos G; Bács-Kiskun County Hospital, Nyíri u. 38, Kecskemét, 6000, Hungary., Pápai Z; Hungarian Army Medical Center, Róbert Károly körút 44, Budapest, 1134, Hungary., Kahán Z; Department of Oncotherapy, University of Szeged, Korányi fasor 12, Szeged, 6720, Hungary. kahan.zsuzsanna@med.u-szeged.hu.

Publikováno v: Pathology oncology research : POR [Pathol Oncol Res] 2017 Jul; Vol. 23 (3), pp. 505-511. Date of Electronic Publication: 2016 Oct 22.